HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blood pressure regulates the activity and function of the Na-K-2Cl cotransporter in vascular smooth muscle.

Abstract
The Na-K-2Cl cotransporter (NKCC1) is one of several transporters that have been linked to hypertension, and its inhibition reduces vascular smooth muscle tone and blood pressure. NKCC1 in the rat aorta is stimulated by vasoconstrictors and inhibited by nitrovasodilators, and this is linked to the contractile state of the smooth muscle. To determine whether blood pressure also regulates NKCC1, we examined the acute effect of hypertension on NKCC1 in rats after aortic coarctation. In the hypertensive aorta (28-mmHg rise in mean blood pressure), an increase in NKCC1 activity (measured as bumetanide-sensitive (86)Rb efflux) was apparent by 16 h and reached a plateau of 62% greater than control at 48 h. In contrast, there was a slight decrease in NKCC1 activity in the hypotensive aorta (21% decrease in mean blood pressure). Measurement of NKCC1 mRNA by real-time PCR revealed a fivefold increase in the hypertensive aorta compared with the hypotensive aorta or sham aorta. The inhibition by bumetanide of isometric force response to phenylephrine was significantly greater in the hypertensive aorta than in the control aorta or hypotensive aorta. We conclude that NKCC1 in rat aortic smooth muscle is regulated by blood pressure, most likely through changes in transporter abundance. This upregulation of NKCC1 is associated with a greater contribution to force generation in the hypertensive aorta. This is the first demonstration that NKCC1 in vascular smooth muscle is regulated by blood pressure and indicates that this transporter is important in the acute response of vascular smooth muscle to hypertension.
AuthorsGengru Jiang, Fatma Akar, Scott L Cobbs, Koba Lomashvilli, Randala Lakkis, Frank J Gordon, Roy L Sutliff, W Charles O'Neill
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 286 Issue 4 Pg. H1552-7 (Apr 2004) ISSN: 0363-6135 [Print] United States
PMID15020309 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Diuretics
  • Enzyme Inhibitors
  • RNA, Messenger
  • Slc12a2 protein, rat
  • Sodium-Potassium-Chloride Symporters
  • Solute Carrier Family 12, Member 2
  • Bumetanide
Topics
  • Animals
  • Aortic Coarctation (physiopathology)
  • Blood Pressure (physiology)
  • Bumetanide (pharmacology)
  • Cardiomegaly (physiopathology)
  • Diuretics (pharmacology)
  • Enzyme Inhibitors (pharmacology)
  • Hypertension (physiopathology)
  • Isometric Contraction (physiology)
  • Male
  • Muscle Contraction (physiology)
  • Muscle, Smooth, Vascular (metabolism, physiology)
  • RNA, Messenger (biosynthesis)
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sodium-Potassium-Chloride Symporters (biosynthesis, metabolism, physiology)
  • Solute Carrier Family 12, Member 2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: